NASDAQ
Enanta Pharmaceuticals, Inc. (ENTA) has a free cash flow growth of 39.44% as of Friday, May 29, 2026. This represents a 211.07% increase compared to its 12-month average of 12.68%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.